1. Home
  2. ICCC vs GMM Comparison

ICCC vs GMM Comparison

Compare ICCC & GMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • GMM
  • Stock Information
  • Founded
  • ICCC 1982
  • GMM 2017
  • Country
  • ICCC United States
  • GMM China
  • Employees
  • ICCC N/A
  • GMM N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • GMM
  • Sector
  • ICCC Health Care
  • GMM
  • Exchange
  • ICCC Nasdaq
  • GMM Nasdaq
  • Market Cap
  • ICCC 55.5M
  • GMM 57.9M
  • IPO Year
  • ICCC 1987
  • GMM 2023
  • Fundamental
  • Price
  • ICCC $6.19
  • GMM $1.79
  • Analyst Decision
  • ICCC
  • GMM
  • Analyst Count
  • ICCC 0
  • GMM 0
  • Target Price
  • ICCC N/A
  • GMM N/A
  • AVG Volume (30 Days)
  • ICCC 18.9K
  • GMM 19.5K
  • Earning Date
  • ICCC 11-13-2025
  • GMM 08-18-2025
  • Dividend Yield
  • ICCC N/A
  • GMM N/A
  • EPS Growth
  • ICCC N/A
  • GMM N/A
  • EPS
  • ICCC 0.20
  • GMM 1.79
  • Revenue
  • ICCC $28,274,756.00
  • GMM $48,171,048.00
  • Revenue This Year
  • ICCC N/A
  • GMM N/A
  • Revenue Next Year
  • ICCC N/A
  • GMM N/A
  • P/E Ratio
  • ICCC $31.45
  • GMM $1.03
  • Revenue Growth
  • ICCC 21.75
  • GMM 41.74
  • 52 Week Low
  • ICCC $3.38
  • GMM $1.66
  • 52 Week High
  • ICCC $7.60
  • GMM $6.21
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 50.47
  • GMM 40.69
  • Support Level
  • ICCC $6.07
  • GMM $1.70
  • Resistance Level
  • ICCC $6.31
  • GMM $1.95
  • Average True Range (ATR)
  • ICCC 0.28
  • GMM 0.09
  • MACD
  • ICCC 0.01
  • GMM -0.01
  • Stochastic Oscillator
  • ICCC 44.19
  • GMM 31.90

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About GMM Global Mofy Metaverse Limited

Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.

Share on Social Networks: